At a glance
ClinicalIndex Comparison RecordN/ACompleted· 540 enrolled
Drug / intervention
galyfilcon A, BC 8.30 +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses
In Brief
A clinical study evaluating galyfilcon A, BC 8.30, lotrafilcon B, BC 8.60, and 1 other intervention for Myopia. Completed, enrolled 540 participants across 35 sites.
Detailed Summary
The purpose of this study is to compare the clinical performance of three silicone hydrogel contact lenses over a 2 week period.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2010
Primary CompletionNov 2010
First PostedNov 2010
TodayJul 2026
First PostedNov 19, 2010
Enrollment StartSep 1, 2010
Primary CompletionNov 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 15.6 years ago
Interventions
galyfilcon A, BC 8.30device
galyfilcon A, BC 8.30 soft contact lens
lotrafilcon B, BC 8.60device
lotrafilcon B, BC 8.60 soft contact lens
comfilcon A, BC 8.60device
comfilcon A, BC 8.60 soft contact lens